You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Advanced therapeutic for Parkinson's Disease
SBC: Inhibikase Therapeutics, Inc. Topic: 999Parkinsonandapos;s Disease (PD) is a progressive neurodegenerative disorder that affects ≈1 million patient in the U.S. annually and 7 to 10 million people worldwide. PD is characterized by disorders of movement, which are caused by the progressive loss of dopamine neurons in the substantia nigra pars compacta (SNpc), and autonomic dysfunction, anxiety, depression, sleep disorders and cognitive ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Human Neural Cell Exosomes as a Therapeutic Treatment for Stroke
SBC: ARUNA BIO, INC. Topic: NINDSProject Summary Cytoprotective and restorative treatments for acute ischemic stroke (AIS) is a major unmet medical need. The current standard of care for stroke patients is centered on recanalization efforts to restore cerebral perfusion through the administration of tissue plasminogen activator (tPA) or mechanical thrombectomy. However, despite a recent extension of recanalization treatment windo ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Addressing Opioid Use Disorder with an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing in Acute and Chronic Low Back Pain.
SBC: MMJ Labs, LLC Topic: NIDAProject Summary The goal of this project is to develop a multimodal neuromodulatory opioid sparing device for low back paindemonstrate effective pain reliefthen evaluate opioid reduction for patients with acute or chronic back pain presenting for treatmentPain and opioid use disorderOUDare intricately relateddependence begins for up towith medications prescribed for paineither directly or through ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of Serious Games and Physical Activities Instructed by a Social Robot for Improving the Well-being of Elderly Individuals with Alzheimer's Disease and Dementia
SBC: Dream Face Technologies, LLC Topic: NIAThe objective of the proposed direct Phase-II SBIR project is to develop and study and the effectiveness of Serious Games and physical Activities played/performed by elderly people with Alzheimer’s disease and AD- related Dementias in interaction with Ryan, our successfully piloted Socially Assistive Robot (SAR). Ryan is an intelligent conversational life-like social robot, designed to improve t ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
HLS- SBIR Phase I: Targeted platelet-capsule hybrids for on demand treatment in hemophilia
SBC: Split Rock Therapeutics, LLC Topic: NHLBIPROJECT SUMMARY ABSTRACTHemophilia A affectspeople in the USclassifying it as an Orphan Diseaseand is characterized by the inability to produce functional factor VIIIfVIIIa plasma protein necessary for blood clot formationof those with severe hemophilia A have inhibitory antibodies to the commonly used drugwhich is intravenous infusion of plasma derived or recombinant fVIIIThese patients represent ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Citizen-Science Technology for HealthyLiving at Home
SBC: Access Sensor Technologies LLC Topic: NIMHDProject Summary Environmental risk factors are attributable toof the chronic respiratory disease burden in the U Sand toof the burden from other non communicable diseasese gcancercardiovascular diseaseand diabetesExposure to environmental risk factors occurs through various forms of water and air pollutionwith a smaller attribution to sources like noiseradiationand physical hazardsMuch of this exp ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Translating an In-Person Brief, Bystander Bullying Intervention (STAC) to a Technology-Based
SBC: KLEIN BUENDEL, INC. Topic: 102Project Summary While studies support the efficacy of comprehensiveschool wide interventions in reducing bullyingthese types of programs can require significant time and financial resources for implementationresulting in barriers to providing school based bullying preventionespecially in low income and rural communitiesAdditionallyalthough training bystanders to act asdefenderson behalf of targets ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Therapeutic hydrogel and hydrogel delivery device for prevention of post-operative atrial fibrillation
SBC: CORAMI LLC Topic: NHLBIPROJECT SUMMARY ABSTRACTAtrial fibrillationAFis a common and chronic cardiac arrhythmia that significantly increases morbiditymortalityand healthcare costsPost operative AF after cardiac surgery is especially commonIt complicates recovery in up toof patients undergoing coronary artery bypass surgeryIn the United States postoperative AF prolongs hospital stayincreases costand increases short and lo ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Preventing Vascular Complications in Type 1 Diabetes: Muscle Metabolic Monitoring
SBC: Infrared Rx, Inc. Topic: NIDDKPreventing Vascular Complications in Type 1 Diabetes: Muscle Metabolic Monitoring Abstract Measurements of muscle metabolism and blood flow using near infrared spectroscopy (NIRS) have progressively increased, as has the number of companies selling NIRS-based devices. This technology represents the present and future modality for non-invasively characterizing normal and abnormal muscle physiology ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
The Diagnostic Utility of the in-vitro "Provoked" D dimer test in patients with suspected pulmonary embolism
SBC: AUGDIMER, LLC Topic: NHLBIProject SummaryThe D Dimer assay is the current diagnostic standard to exclude patients of VTE due to its high sensitivityHoweverD Dimer levels are commonly elevated in patients without thromboembolismleading to poor specificity and poor positive predictive valuePPVDue to the lack of a robust diagnostic tool for VTEwe propose a novel advancement upon current DDimer testing which improves specifici ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health